Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
49
ATRC Quote, Financials, Valuation and Earnings
Last price:
$41.45
Seasonality move
:
-4.78%
Day range:
$37.31 - $41.79
52-week range:
$28.29 - $43.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.80x
P/B ratio:
4.33x
Volume:
1M
Avg. volume:
509.9K
1-year change:
12.15%
Market cap:
$2.1B
Revenue:
$465.3M
EPS (TTM):
-$0.61
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $206.5M | $274.3M | $330.4M | $399.2M | $465.3M | |
| Revenue Growth (YoY) | -10.52% | 32.83% | 20.43% | 20.85% | 16.55% | |
| Cost of Revenues | $57.2M | $68.5M | $84.4M | $101.8M | $120.8M | |
| Gross Profit | $149.3M | $205.9M | $245.9M | $297.4M | $344.5M | |
| Gross Profit Margin | 72.29% | 75.04% | 74.44% | 74.5% | 74.04% | |
| R&D Expenses | $43.1M | $48.5M | $57.3M | $73.9M | $81.2M | |
| Selling, General & Admin | $150.8M | $204.6M | $231.3M | $253.1M | $291.4M | |
| Other Inc / (Exp) | $333K | $102.1M | -$537K | -$31K | -$1.7M | |
| Operating Expenses | $193.9M | $253.2M | $288.6M | $328.5M | $372.5M | |
| Operating Income | -$44.6M | -$47.3M | -$42.7M | -$31.1M | -$28M | |
| Net Interest Expenses | $3.8M | $4.9M | $5M | $6.9M | $6.4M | |
| EBT. Incl. Unusual Items | -$48M | $50.4M | -$46.2M | -$29.8M | -$43.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $114K | $188K | $268K | $591K | $1M | |
| Net Income to Company | -$48.2M | $50.2M | -$46.5M | -$30.4M | -$44.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$48.2M | $50.2M | -$46.5M | -$30.4M | -$44.7M | |
| Basic EPS (Cont. Ops) | -$1.14 | $1.11 | -$1.02 | -$0.66 | -$0.95 | |
| Diluted EPS (Cont. Ops) | -$1.14 | $1.09 | -$1.02 | -$0.66 | -$0.95 | |
| Weighted Average Basic Share | $42.1M | $45.1M | $45.7M | $46.3M | $47M | |
| Weighted Average Diluted Share | $42.1M | $46M | $45.7M | $46.3M | $47M | |
| EBITDA | -$33.6M | -$36.9M | -$31M | -$16.3M | -$9.3M | |
| EBIT | -$43.2M | -$47.3M | -$42.7M | -$31.1M | -$28M | |
| Revenue (Reported) | $206.5M | $274.3M | $330.4M | $399.2M | $465.3M | |
| Operating Income (Reported) | -$44.6M | -$47.3M | -$42.7M | -$31.1M | -$28M | |
| Operating Income (Adjusted) | -$43.2M | -$47.3M | -$42.7M | -$31.1M | -$28M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $70.5M | $83.2M | $98.3M | $115.9M | $134.3M | |
| Revenue Growth (YoY) | 28.68% | 18.15% | 18.07% | 17.93% | 15.84% | |
| Cost of Revenues | $18.2M | $21.5M | $25.2M | $29.9M | $33.7M | |
| Gross Profit | $52.2M | $61.7M | $73.1M | $86M | $100.6M | |
| Gross Profit Margin | 74.12% | 74.13% | 74.4% | 74.22% | 74.9% | |
| R&D Expenses | $11.3M | $15.2M | $20.4M | $20.2M | $22.1M | |
| Selling, General & Admin | $49.9M | $57.3M | $61.6M | $73.2M | $78.2M | |
| Other Inc / (Exp) | $107.4M | -$549K | -$62K | $260K | -- | |
| Operating Expenses | $61.2M | $72.4M | $81.2M | $93.4M | $100.4M | |
| Operating Income | -$8.9M | -$10.7M | -$8.1M | -$7.4M | $208K | |
| Net Interest Expenses | $1.4M | $1.3M | $1.8M | $1.7M | $1.5M | |
| EBT. Incl. Unusual Items | $97.1M | -$12.2M | -$9M | -$7.5M | -$86K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $38K | $46K | $47K | $322K | $181K | |
| Net Income to Company | $97.1M | -$12.3M | -$9.1M | -$7.9M | -$267K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $97.1M | -$12.3M | -$9.1M | -$7.9M | -$267K | |
| Basic EPS (Cont. Ops) | $2.15 | -$0.27 | -$0.20 | -$0.17 | -$0.01 | |
| Diluted EPS (Cont. Ops) | $2.11 | -$0.27 | -$0.20 | -$0.17 | -$0.01 | |
| Weighted Average Basic Share | $45.3M | $45.8M | $46.4M | $47.1M | $47.9M | |
| Weighted Average Diluted Share | $46.1M | $45.8M | $46.4M | $47.1M | $47.9M | |
| EBITDA | -$6.1M | -$7.7M | -$4M | -$2.5M | $5.4M | |
| EBIT | -$8.9M | -$10.7M | -$8.1M | -$7.4M | $208K | |
| Revenue (Reported) | $70.5M | $83.2M | $98.3M | $115.9M | $134.3M | |
| Operating Income (Reported) | -$8.9M | -$10.7M | -$8.1M | -$7.4M | $208K | |
| Operating Income (Adjusted) | -$8.9M | -$10.7M | -$8.1M | -$7.4M | $208K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $258.8M | $315.6M | $380.7M | $447.6M | $518.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $65.6M | $79.7M | $95.8M | $115.9M | $133.3M | |
| Gross Profit | $193.3M | $235.8M | $284.9M | $331.7M | $385M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $45.6M | $57.4M | $66.9M | $80.5M | $89.6M | |
| Selling, General & Admin | $205.1M | $229.5M | $241M | $286.9M | $304.9M | |
| Other Inc / (Exp) | $103M | -$968K | $176K | -$1.1M | -- | |
| Operating Expenses | $241.1M | $286.9M | $312.1M | $365.9M | $394.5M | |
| Operating Income | -$47.8M | -$51M | -$27.2M | -$34.2M | -$9.5M | |
| Net Interest Expenses | $5M | $4.5M | $6.7M | $6.8M | $5.8M | |
| EBT. Incl. Unusual Items | $45.6M | -$55.8M | -$24.5M | -$37.8M | -$27.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $233K | $200K | $339K | $1.1M | $947K | |
| Net Income to Company | $45.4M | -$56M | -$24.8M | -$38.9M | -$28.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $45.4M | -$56M | -$24.8M | -$38.9M | -$28.8M | |
| Basic EPS (Cont. Ops) | $0.99 | -$1.23 | -$0.54 | -$0.83 | -$0.61 | |
| Diluted EPS (Cont. Ops) | $0.95 | -$1.23 | -$0.54 | -$0.83 | -$0.61 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$38M | -$39.4M | -$13.7M | -$16.1M | $10.8M | |
| EBIT | -$47.8M | -$51M | -$27.2M | -$34.2M | -$9.5M | |
| Revenue (Reported) | $258.8M | $315.6M | $380.7M | $447.6M | $518.3M | |
| Operating Income (Reported) | -$47.8M | -$51M | -$27.2M | -$34.2M | -$9.5M | |
| Operating Income (Adjusted) | -$47.8M | -$51M | -$27.2M | -$34.2M | -$9.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $201.1M | $242.4M | $292.7M | $341M | $394M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $50.3M | $61.5M | $72.9M | $88.4M | $100.9M | |
| Gross Profit | $150.8M | $180.8M | $219.8M | $252.6M | $293.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $34.7M | $43.6M | $53.1M | $59.7M | $67.4M | |
| Selling, General & Admin | $156M | $175.8M | $185.5M | $219.2M | $232.7M | |
| Other Inc / (Exp) | $107.4M | -$753K | -$40K | -$1.2M | $632K | |
| Operating Expenses | $190.7M | $219.4M | $242.9M | $278.1M | $300.1M | |
| Operating Income | -$39.9M | -$38.5M | -$23.1M | -$25.5M | -$6.9M | |
| Net Interest Expenses | $3.6M | $3.4M | $5.1M | $5M | $4.4M | |
| EBT. Incl. Unusual Items | $64.1M | -$42.1M | -$20.4M | -$28.4M | -$12.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $135K | $147K | $218K | $758K | $681K | |
| Net Income to Company | $63.9M | -$42.3M | -$20.6M | -$29.1M | -$13.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $63.9M | -$42.3M | -$20.6M | -$29.1M | -$13.2M | |
| Basic EPS (Cont. Ops) | $1.41 | -$0.93 | -$0.45 | -$0.62 | -$0.28 | |
| Diluted EPS (Cont. Ops) | $1.37 | -$0.93 | -$0.45 | -$0.62 | -$0.28 | |
| Weighted Average Basic Share | $134.9M | $137M | $138.8M | $140.7M | $143M | |
| Weighted Average Diluted Share | $135.8M | $137M | $138.8M | $140.7M | $143M | |
| EBITDA | -$32M | -$29.7M | -$12.4M | -$11.6M | $8.5M | |
| EBIT | -$39.6M | -$38.5M | -$23.1M | -$25.5M | -$6.9M | |
| Revenue (Reported) | $201.1M | $242.4M | $292.7M | $341M | $394M | |
| Operating Income (Reported) | -$39.9M | -$38.5M | -$23.1M | -$25.5M | -$6.9M | |
| Operating Income (Adjusted) | -$39.6M | -$38.5M | -$23.1M | -$25.5M | -$6.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $41.9M | $119.1M | $121.1M | $137.3M | $122.7M | |
| Short Term Investments | $202.3M | $75.4M | $63M | $53M | -- | |
| Accounts Receivable, Net | $23.1M | $33M | $42.7M | $52.5M | $60.3M | |
| Inventory | $35M | $39M | $45.9M | $67.9M | $75.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.3M | $5M | $5.5M | $8.6M | $9.4M | |
| Total Current Assets | $306.7M | $196.1M | $215.2M | $266.2M | $267.8M | |
| Property Plant And Equipment | $30.2M | $36.2M | $42.6M | $46.8M | $47.4M | |
| Long-Term Investments | $14.2M | $104.3M | $51.5M | -- | -- | |
| Goodwill | $234.8M | $234.8M | $234.8M | $234.8M | $234.8M | |
| Other Intangibles | $128.2M | $43M | $39.3M | $64M | $56.5M | |
| Other Long-Term Assets | $440K | $955K | $2M | $2.2M | $2.9M | |
| Total Assets | $714.5M | $615.3M | $585.4M | $613.9M | $609.3M | |
| Accounts Payable | $12.7M | $18.6M | $19.9M | $27.4M | $25M | |
| Accrued Expenses | $7.1M | $2.7M | $3.3M | $2.5M | $3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $2.8M | |
| Other Current Liabilities | -- | $1.8M | -- | -- | -- | |
| Total Current Liabilities | $49.1M | $56.4M | $58.4M | $74.6M | $73.4M | |
| Long-Term Debt | $53.4M | $73.9M | $69.1M | $72M | $73.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $302.1M | $131.6M | $128.7M | $147.8M | $148.4M | |
| Common Stock | $45K | $46K | $47K | $48K | $49K | |
| Other Common Equity Adj | $312K | -$948K | -$4.1M | -$993K | -$1M | |
| Common Equity | $412.4M | $483.8M | $456.8M | $466.2M | $461M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $412.4M | $483.8M | $456.8M | $466.2M | $461M | |
| Total Liabilities and Equity | $714.5M | $615.3M | $585.4M | $613.9M | $609.3M | |
| Cash and Short Terms | $244.2M | $119.1M | $121.1M | $137.3M | $122.7M | |
| Total Debt | $61.9M | $74.8M | $70.1M | $73M | $74.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $119.7M | $122.6M | $133M | $130.3M | $147.9M | |
| Short Term Investments | $79.9M | $73.8M | $52.4M | -- | -- | |
| Accounts Receivable, Net | $33.5M | $41.5M | $51.5M | $54.9M | $63M | |
| Inventory | $38.6M | $44M | $61.9M | $76.5M | $79M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.9M | $4.2M | $6.3M | $7.5M | -- | |
| Total Current Assets | $195.7M | $212.3M | $252.7M | $269.3M | $301.1M | |
| Property Plant And Equipment | $32.4M | $42.5M | $45.4M | $49.6M | $46.4M | |
| Long-Term Investments | $105.1M | $51.4M | -- | -- | -- | |
| Goodwill | $234.8M | $234.8M | $234.8M | $234.8M | -- | |
| Other Intangibles | $44M | $40.1M | $65.7M | $58.4M | -- | |
| Other Long-Term Assets | $1.1M | $829K | $1.6M | $3M | -- | |
| Total Assets | $613M | $581.9M | $600.3M | $615.1M | $635.4M | |
| Accounts Payable | $17.5M | $24.4M | $24.5M | $31.7M | $25.5M | |
| Accrued Expenses | $1.1M | $1.3M | $2.1M | $2.3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $2M | -- | $2.7M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $54M | $57.6M | $82.5M | $74.4M | $77.8M | |
| Long-Term Debt | $68.3M | $72.8M | $53.7M | $74.4M | $79.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $124.5M | $131.6M | $137.4M | $150M | $158.9M | |
| Common Stock | $46K | $46K | $47K | $49K | $50K | |
| Other Common Equity Adj | -$213K | -$5.3M | -$2.2M | -$147K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $488.5M | $450.3M | $462.8M | $465M | $476.5M | |
| Total Liabilities and Equity | $613M | $581.9M | $600.3M | $615.1M | $635.4M | |
| Cash and Short Terms | $119.7M | $122.6M | $133M | $130.3M | $147.9M | |
| Total Debt | $70.2M | $73.8M | $73.1M | $75.6M | $81.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$48.2M | $50.2M | -$46.5M | -$30.4M | -$44.7M | |
| Depreciation & Amoritzation | $9.5M | $10.4M | $11.7M | $14.8M | $18.7M | |
| Stock-Based Compensation | $22.6M | $28.1M | $28.8M | $35.7M | $40.4M | |
| Change in Accounts Receivable | $5.1M | -$10.1M | -$9M | -$9.9M | -$8.3M | |
| Change in Inventories | -$5.3M | -$4.3M | -$7.3M | -$21.8M | -$7.7M | |
| Cash From Operations | -$19.9M | -$13.8M | -$22.1M | $4.4M | $11.1M | |
| Capital Expenditures | $5.3M | $9.8M | $16.9M | $42M | $11.5M | |
| Cash Acquisitions | -- | -- | -- | -- | $12M | |
| Cash From Investing | -$156.2M | $23.5M | $44M | $21.8M | $30.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $5M | -- | -- | $61.2M | |
| Long-Term Debt Repaid | -$667K | -$5.8M | -$899K | -$992K | -$62.9M | |
| Repurchase of Common Stock | -$13M | $18M | $12.2M | $6.6M | $7M | |
| Other Financing Activities | -$35K | -$1.2M | -- | -$60K | -- | |
| Cash From Financing | $189.4M | -$7.6M | -$7.1M | $28K | -$2.5M | |
| Beginning Cash (CF) | $28.5M | $43.7M | $58.1M | $84.3M | $122.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.3M | $1.7M | $14.4M | $26.2M | $38.4M | |
| Ending Cash (CF) | $41.9M | $45M | $72.2M | $110.5M | $160.7M | |
| Levered Free Cash Flow | -$25.1M | -$23.5M | -$39M | -$37.6M | -$324K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $97.1M | -$12.3M | -$9.1M | -$7.9M | -$267K | |
| Depreciation & Amoritzation | $2.8M | $3M | $4.1M | $4.9M | $5.2M | |
| Stock-Based Compensation | $6.8M | $7M | $8.7M | $10.4M | $12.4M | |
| Change in Accounts Receivable | $216K | -$228K | -$3.4M | $893K | $3M | |
| Change in Inventories | -$1.1M | -$3M | -$6.7M | -$2.7M | -$2.6M | |
| Cash From Operations | -$232K | -$1.8M | $1.5M | $20M | $26.7M | |
| Capital Expenditures | $1.5M | $5.1M | $3.6M | $3.6M | $2.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$25.1M | -$3.2M | $11.9M | $4.4M | -$2.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.9M | -$225K | -$248K | -$269K | -- | |
| Repurchase of Common Stock | $1.4M | $563K | $435K | $63K | $357K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$2.3M | -$405K | $132K | -$333K | $6M | |
| Beginning Cash (CF) | $39.9M | $48.8M | $80.6M | $130.3M | $147.9M | |
| Foreign Exchange Rate Adjustment | -$140K | -$305K | -$166K | $237K | -$26K | |
| Additions / Reductions | -$27.7M | -$5.7M | $13.4M | $24.3M | $30.1M | |
| Ending Cash (CF) | $12M | $42.8M | $93.8M | $154.9M | $177.9M | |
| Levered Free Cash Flow | -$1.7M | -$6.9M | -$2.1M | $16.4M | $24.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $45.4M | -$56M | -$24.8M | -$38.9M | -$28.8M | |
| Depreciation & Amoritzation | $9.8M | $11.6M | $13.6M | $18.1M | $20.3M | |
| Stock-Based Compensation | $27.1M | $29.1M | $33.6M | $39.3M | $43.8M | |
| Change in Accounts Receivable | -$8.2M | -$8.5M | -$8.9M | -$3.2M | -$7.9M | |
| Change in Inventories | -$4.3M | -$6.2M | -$17.6M | -$14.4M | -$1.9M | |
| Cash From Operations | -$10.1M | -$21.9M | $440K | $10.4M | $42.1M | |
| Capital Expenditures | $8.1M | $15.4M | $43.4M | $11.6M | $10.1M | |
| Cash Acquisitions | -- | -- | -- | -- | $17M | |
| Cash From Investing | $20.4M | $38.1M | $31.6M | $42.1M | -$26.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $61.2M | -- | |
| Long-Term Debt Repaid | -$2.5M | -$4.2M | -$968K | -$62.9M | -- | |
| Repurchase of Common Stock | $18M | $12.2M | $6.5M | $6.8M | $11.1M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$3.7M | -$6.5M | -$349K | -$3M | $1.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6.5M | $8.9M | $31.8M | $49.7M | $17.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$18.2M | -$37.3M | -$42.9M | -$1.2M | $31.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $63.9M | -$42.3M | -$20.6M | -$29.1M | -$13.2M | |
| Depreciation & Amoritzation | $7.6M | $8.8M | $10.6M | $13.9M | $15.4M | |
| Stock-Based Compensation | $20.5M | $21.6M | $26.4M | $30M | $33.4M | |
| Change in Accounts Receivable | -$10.6M | -$9M | -$8.9M | -$2.2M | -$1.9M | |
| Change in Inventories | -$3.8M | -$5.7M | -$16M | -$8.6M | -$2.7M | |
| Cash From Operations | -$14.1M | -$22.2M | $394K | $6.4M | $37.3M | |
| Capital Expenditures | $7M | $12.7M | $39.2M | $8.8M | $7.4M | |
| Cash Acquisitions | -- | -- | -- | -- | $5M | |
| Cash From Investing | $22.4M | $37M | $24.6M | $44.9M | -$11.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $61.2M | -- | |
| Long-Term Debt Repaid | -$2.3M | -$662K | -$731K | -$62.6M | -$579K | |
| Repurchase of Common Stock | -$15.1M | $12.1M | $6.5M | $6.8M | $10.9M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$10.1M | -$9M | -$2.3M | -$5.3M | -$922K | |
| Beginning Cash (CF) | $167.2M | $131.5M | $225.2M | $301.3M | $365.5M | |
| Foreign Exchange Rate Adjustment | -$255K | -$607K | -$167K | $71K | $707K | |
| Additions / Reductions | -$1.9M | $5.2M | $22.5M | $46M | $25.1M | |
| Ending Cash (CF) | $165M | $136.1M | $247.5M | $347.4M | $391.4M | |
| Levered Free Cash Flow | -$21.1M | -$34.9M | -$38.8M | -$2.4M | $29.9M | |
Get ATRC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ATRC
Sector
P/E ratio
--
23.92x
PEG ratio
-31.34x
-0.01x
P/B ratio
4.33x
1.81x
Price / LTM sales
3.80x
1.60x
Growth Metrics
ATRC
Sector
Revenue growth
15.84%
4.35%
Earnings growth
96.64%
9.8%
Revenue (5-year growth)
15.05%
6.41%
Earnings forecast
-$0.05
-$0.18
Profitability
ATRC
Sector
Profitability FY 2024
$344.5M
$3.3M
Return on invested capital
-5.3%
-32.69%
Return on assets
-4.7%
-29.29%
Return on equity
-6.2%
-38.5%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Jan
28
Balance Sheet
ATRC
Sector
Total cash
$147.9M
$25.6M
Short term investments
--
$25.1M
Total assets
$609.3M
$75.5M
Long term debt
$81.3M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is up 18.69% over the past day.
Sell
44
RGC alert for Jan 16
Regencell Bioscience Holdings Ltd. [RGC] is down 14.64% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 11.83% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
